[Anti-HCV antibodies among hemodialysed and kidney-transplanted patients].
We have studied from two hemodialysed centers to determine the prevalence of hepatitis C virus infection in hemodialysis 142 patients and 147 renal-transplant patients. Serum samples were tested for antibody by "Ortho HCV 2.0 ELISA test System" second generation assay. Antibody to hepatitis C virus was detected in 81 (57.04%) and 85 (57.82%) patients respectively. Age-related differences were not clear, but significantly were noted in hemodialysis patients. Patients with a history blood transfusion in both groups tended to have significantly high anti-HCV positivity rate. There was a tendency for a longer duration of hemodialysis to coincide with higher positivity anti-HCV.
Juszczyk
J
J
Klinika Chorób Zakaźnych AM, Poznaniu.
Flieger
J
J
Syczewska
M
M
Krzymański
M
M
D000328:Adult; D001803:Blood Transfusion; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000276:immunology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D013997:Time Factors
D006508:Hepatitis Antibodies
Markery hepatitis C (anty-HCV) u chorych dializowanych i po przeszczepie nerek.